Literature DB >> 15031798

Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice.

Laura A Kerepesi1, Thomas J Nolan, Gerhard A Schad, Sara Lustigman, De'Broski R Herbert, Paul B Keiser, Thomas B Nutman, Alejandro J Krolewiecki, David Abraham.   

Abstract

Protective immunity to larval Strongyloides stercoralis in mice has been shown to be dependent on antibody, complement, and granulocytes. The goals of the present study was to determine the following: (1) whether human serum could passively transfer immunity to mice, (2) the mechanism by which the serum mediated killing, and (3) whether the antigens (Ags) recognized by the protective human antibody could induce protective immunity in mice. Immunoglobulin G (IgG) from a S. stercoralis-seropositive individual passively transferred immunity to mice. The antibody required granulocytes, but not eosinophils, and complement activation to kill the larvae. Antibody-dependent cellular cytotoxicity was not required for larval killing. Immunization of mice with soluble larval Ags isolated by use of the protective immune IgG resulted in protective immunity. In conclusion, immunity could be transferred to mice by IgG from immune humans, and Ags identified by the immune human IgG induced protective immunity in mice, which thereby suggests their possible use in a vaccine against this infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031798     DOI: 10.1086/382484

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model.

Authors:  Sandra Bonne-Année; Jessica A Hess; David Abraham
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

2.  Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice.

Authors:  David Abraham; Jessica A Hess; Rojelio Mejia; Thomas J Nolan; James B Lok; Sara Lustigman; Thomas B Nutman
Journal:  Vaccine       Date:  2011-08-19       Impact factor: 3.641

3.  DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in mice.

Authors:  Laura A Kerepesi; Paul B Keiser; Thomas J Nolan; Gerhard A Schad; David Abraham; Thomas B Nutman
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 4.  To B or not to B: B cells and the Th2-type immune response to helminths.

Authors:  Nicola Harris; William C Gause
Journal:  Trends Immunol       Date:  2010-12-14       Impact factor: 16.687

5.  Update on strongyloidiasis in the immunocompromised host.

Authors:  Luis A Marcos; Angélica Terashima; Marco Canales; Eduardo Gotuzzo
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

Review 6.  Strongyloides hyperinfection and hypogammaglobulinemia.

Authors:  Raymond C S Seet; Lee Gong Lau; Paul Ananth Tambyah
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

7.  Strongyloides stercoralis hyperinfection presenting as subacute small bowel obstruction following immunosuppressive chemotherapy for multiple myeloma.

Authors:  Adrian Matthew Shields; Rashida Goderya; Mustafa Atta; Prakash Sinha
Journal:  BMJ Case Rep       Date:  2014-01-27

8.  B-cells get the T-cells but antibodies get the worms.

Authors:  Richard J Pleass; Jerzy M Behnke
Journal:  Trends Parasitol       Date:  2009-09-04

Review 9.  Context-dependent roles of B cells during intestinal helminth infection.

Authors:  Aidil Zaini; Kim L Good-Jacobson; Colby Zaph
Journal:  PLoS Negl Trop Dis       Date:  2021-05-13

10.  Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.

Authors:  Martin Montes; Cesar Sanchez; Kristien Verdonck; Jordan E Lake; Elsa Gonzalez; Giovanni Lopez; Angelica Terashima; Thomas Nolan; Dorothy E Lewis; Eduardo Gotuzzo; A Clinton White
Journal:  PLoS Negl Trop Dis       Date:  2009-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.